arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

AIM ImmunoTech Inc.

AIM

$0.21 0.00 (-2.24%) at close

18 Visible periods

27 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

AIM ImmunoTech Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth -48.2% ↘

Op. Margin —

ROIC 173.6% ↗

FCF / Share $-6.77 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity -0.46

info Valuation on last close. End-of-day price, Sep 23, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$88.00K

↓ -48.2% —

Net Income Profit after all expenses

$-13.96M

↑ +19.4% —

FCF / Share Free cash flow per share

$-6.77

↑ +74.6% —

Long-Term Debt Long-term obligations

$4.48M

↑ +59.5% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

100

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue Growth YoY (%)	-48.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-703%)	-15.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-298%)	43.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+441%)	4.4% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-44%)	-17.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-315%)	16.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+105%)	-61.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-873%)	-16.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-300%)	375.0% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4588%)	-30.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-485%)	-32.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-506%)	31.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+292%)	-29.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-470%)	32.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+304%)	19.3% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+141%)	21.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+170%)	—	—
EPS Growth YoY (%)	72.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-5053.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-50.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	19.4% Good ↑ Good Improving Year-over-year change in net income	40.2% Excellent ↑ Excellent Improving Year-over-year change in net income	-48.9% Weak ↓ Weak Declining Year-over-year change in net income	-1.7% Weak ↑ Weak Improving Year-over-year change in net income	-32.8% Weak ↓ Weak Declining Year-over-year change in net income	-51.1% Weak ↓ Weak Declining Year-over-year change in net income	2.9% Caution ↓ Caution Declining Year-over-year change in net income	-18.8% Weak ↓ Weak Declining Year-over-year change in net income	-10.1% Weak ↓ Weak Declining Year-over-year change in net income	50.7% Excellent ↑ Excellent Improving Year-over-year change in net income	12.7% Fair ↑ Fair Improving Year-over-year change in net income	-7.6% Weak ↑ Weak Improving Year-over-year change in net income	6.5% Fair ↑ Fair Improving Year-over-year change in net income	-92.5% Weak ↓ Weak Declining Year-over-year change in net income	31.4% Excellent Excellent Year-over-year change in net income	-83.0% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	74.6% Excellent Excellent Year-over-year change in free cash flow	-5979.1% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	-14.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	8.0% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	7.4% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	0.2% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-28.3% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-28.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	15.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	40.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	30.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-15.0% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-14.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	7.0% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	3.6% Caution Caution Compound annual revenue growth over 3 years	24.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-11.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	4.0% Caution ↑ Caution Improving Compound annual revenue growth over 5 years	-11.3% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-20.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	8.0% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	4.2% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	-6.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	19.6% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	15.5% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-10.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-0.3% Weak Weak Compound annual revenue growth over 5 years	12.2% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
FCF / Net Income (x)	0.78x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.07x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.32x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.34x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Return on Invested Capital (%)	173.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-1051.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-246.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-18.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-64.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-118.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-103.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-70.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-64.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—
Return on Capital (%) (%)	-201.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-229.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-164.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-61.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-83.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-80.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-73.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-64.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-53.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-31.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	142.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+851%)	—	-283.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1987%)	-50.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-437%)	-33.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-324%)	-23.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-257%)	-73.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-592%)	-189.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1364%)	-94.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-733%)	-48.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-423%)	-74.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-598%)	—	—	—	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Debt to Equity (x)	-0.46x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-176%)	-2.12x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-454%)	—	—	—	0.03x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.18x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	0.49x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-19%)	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-14.36x Weak Weak Operating income divided by interest expense Optimal: > 5x	-33.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-281.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-22.55x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-336.30x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-57.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-82.13x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-5550.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1736.27x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1072.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-847.50x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-348.66x Weak Weak Operating income divided by interest expense Optimal: > 5x	-1489.73x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$1.49M	$1.11M	$-5.44M	$-27.05M	$-32.09M	$-36.40M	$848.00K	$2.22M	$-1.41M	$-2.41M	$-2.12M	$-2.16M	$-803.00K	$-2.21M	$-3.10M	$-2.92M	$-58.07M	$-6.12M
Debt / EBITDA (x)	-0.38x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.14x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-0.15x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.24x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Revenue per Share (USD)	$0.05	$0.30	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-8.62	$-30.92	$-0.60	$-0.40	$-0.40	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-6.77	$-26.61	$-0.44	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-3.19	$-2.02	$0.21	$0.80	$1.19	$1.45	$1.24	$0.11	$0.26	$0.64	$0.99	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$-3.19	$-2.02	$0.21	$0.80	$1.19	$1.45	$1.24	$0.11	$0.26	$0.64	$0.99	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	1.62M	560,169	48.59M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Working Capital (USD)	$-2.93M	$-5.36M	$5.90M	$34.96M	$49.54M	$39.21M	$9.32M	$-1.49M	$798.00K	$4.51M	$8.14M	$12.07M	$16.02M	$32.08M	$26.72M	$33.84M	—	—
LT Debt (USD)	$4.48M	$2.81M	—	—	—	$2.11M	$2.32M	$2.52M	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$-9.78M	$-1.32M	$10.23M	$38.47M	$56.88M	$61.29M	$12.91M	$5.17M	$8.70M	$15.50M	$20.37M	—	—	—	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗	FY 2009 Dec 31, 2009 10-K ↗	FY 2008 Dec 31, 2008 10-K ↗
Sales/Revenue/Turnover (USD)	$88.00K	$170.00K	$202.00K	$141.00K	$135.00K	$163.00K	$140.00K	$367.00K	$437.00K	$92.00K	$133.00K	$197.00K	$150.00K	$213.00K	$161.00K	$135.00K	$111.00K	—
Depreciation Expense (USD)	$37.00K	$37.00K	$39.00K	$38.00K	$659.00K	$665.00K	$735.00K	$856.00K	$948.00K	$1.12M	$941.00K	$665.00K	$671.00K	$643.00K	$465.00K	$407.00K	$359.00K	—
Net Income, GAAP (USD)	$-13.96M	$-17.32M	$-28.96M	$-19.45M	$-19.13M	$-14.40M	$-9.53M	$-9.81M	$-8.26M	$-7.50M	$-15.23M	$-17.45M	$-16.23M	$-17.35M	$-9.02M	$-13.14M	$-7.18M	—
Operating Cash Flow (USD)	$-10.96M	$-14.89M	$-21.27M	$-16.11M	$-13.96M	$-10.37M	$-9.07M	$-10.64M	$-7.94M	$-7.38M	$-16.05M	$-13.92M	$-16.83M	$-13.14M	$-10.10M	$-11.89M	$-9.30M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters

AIM ImmunoTech Inc.

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare AIM with peers